Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating

Jul 8, 2025 - 21:01

0

Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating

Related Posts

US miners eye copper comeback as demand rises

US miners eye copper comeback as demand rises

Mar 24, 2025 0

Risks of buy now, pay later: 'Ticket to overspending,' expert says

Risks of buy now, pay later: 'Ticket to overspending,' ...

Mar 24, 2025 0

Segway recalls 220,000 scooters after consumers report injuries, including broken bones

Segway recalls 220,000 scooters after consumers report ...

Mar 24, 2025 0

Fire breaks out at Walt Disney World's EPCOT as dark smoke is caught on camera billowing across park

Fire breaks out at Walt Disney World's EPCOT as dark sm...

Mar 24, 2025 0

Elon Musk sounds off about Tesla drivers reportedly given low Uber ratings amid nationwide protests

Elon Musk sounds off about Tesla drivers reportedly giv...

Mar 24, 2025 0

23andMe files for bankruptcy as California AG urges customers to delete data

23andMe files for bankruptcy as California AG urges cus...

Mar 24, 2025 0